EUVIMEDEUVIMED entdecken
Kohortenstudie

Delays From Clinical Manifestations to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A National Retrospective Cohort Study

Joshua D Mitchell iD, Margarita Udall iD, Liana Hennum iD, Hanh Dung Dao iD, Bret Zeldow iD, Elizabeth Nagelhout, Kevin M Alexander iD, Richard K Cheng iD

Journal of the American Heart Association · 04.11.2026

DOI: 10.1161/jaha.125.048942 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Heart Association, online erschienen am 04.11.2026. Verfasst von Joshua D Mitchell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Amyloid Center of Excellence, Cardiovascular Division Washington University School of Medicine St Louis MO USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a progressive, life‐threatening condition. Timely and accurate diagnosis remains a challenge. We assessed time from first recorded clinical manifestation to ATTR‐CM diagnosis in the United States and characterized manifestations associated with diagnostic delays.

Methods

Retrospective analysis of US claims data (Komodo Healthcare Map, July 1, 2016–June 30, 2024). Patients were required to have ≥3 years of continuous enrollment before diagnosis.

Results

Among 7509 patients, mean age 75.9 years, 63.2% male, 54.5% White, and 28.6% Black. Patients had a median of 8 manifestations before diagnosis; median observed time from first recorded manifestation to diagnosis was 5.2 years, shorter for variant versus wild‐type ATTR‐CM (4.4 versus 5.2 years). Within 3 years before diagnosis, patients had a mean of 12.04 (95% CI, 11.75–12.35) primary care physician visits and 14.45 (95% CI, 14.10–14.80) specialists of interest visits, most commonly with cardiologists and ophthalmologists. In adjusted analyses, variant ATTR‐CM was associated with shorter time to diagnosis (β, −0.41 years [95% CI, −0.56 to −0.26]), whereas comorbidities, including hypertension (β, 0.46 years [95% CI, 0.27–0.64]), were associated with longer delays.

Conclusions

The diagnostic trajectory for ATTR‐CM can be prolonged and challenging, leading to more advanced disease at diagnosis and increased burden. Raising awareness may provide an opportunity for earlier diagnosis.

Schlagwörter

Stichwörter der Autor:innen

ATTRv‐CMATTRwt‐CMdiagnosisdiagnostic delaytransthyretin amyloid cardiomyopathy

Autor:innen und Institutionen

  • Amyloid Center of Excellence, Cardiovascular Division Washington University School of Medicine St Louis MO USA.
  • BridgeBio Pharma, Inc. San Francisco CA USA.
  • Genesis Research Group Hoboken NJ USA.
  • Stanford Amyloid Center, Division of Cardiovascular Medicine Stanford University School of Medicine Stanford CA USA.
  • Department of Medicine, Division of Cardiology University of Washington Seattle WA USA.

ORCID-Profile: Joshua D Mitchell, Margarita Udall, Liana Hennum, Hanh Dung Dao, Bret Zeldow, Kevin M Alexander, Richard K Cheng

Zitieren

APA

Mitchell, J. D., Udall, M., Hennum, L., Dao, H. D., Zeldow, B., Nagelhout, E., Alexander, K. M., & Cheng, R. K. (2026). Delays From Clinical Manifestations to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A National Retrospective Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.048942

Vancouver

Mitchell JD, Udall M, Hennum L, Dao HD, Zeldow B, Nagelhout E, et al. Delays From Clinical Manifestations to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A National Retrospective Cohort Study. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.048942

BibTeX
@article{Mitchell2026,
  author = {Mitchell, Joshua D and Udall, Margarita and Hennum, Liana and Dao, Hanh Dung and Zeldow, Bret and Nagelhout, Elizabeth and Alexander, Kevin M and Cheng, Richard K},
  title = {Delays From Clinical Manifestations to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A National Retrospective Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.048942}
}
Kostenlos starten →